VALEANT PHARMACEUTICALS NEW ZEALAND LIMITED (in liquidation) 10 July 2019

Notice of Appointment of Liquidators Pursuant to Section 241(2)(a) of the Companies Act 1993 Colin Owens and David Vance of Deloitte were appointed liquidators, jointly and severally, of VALEANT PHARMACEUTICALS NEW ZEALAND LIMITED (in liquidation) by shareholder special resolution on 5 July 2019 at 9.00am. 16 August 2019 is fixed as the last day for creditors to lodge and establish any priority their claims may have. Creditors who fail to lodge a claim by the distribution date will be excluded from that distribution and may not object to that distribution. Creditors claiming a security interest should urgently provide details to the liquidators. Enquiries may be made to David Ernest at Deloitte, PO Box 2691, Wellington, 6140. Telephone: (04) 831 2444. DAVID VANCE, Liquidator.


Report an error
Category
Appointment/Release of Liquidators
Legislation
Companies Act
Debtor(s)

VALEANT PHARMACEUTICALS NEW ZEALAND LIMITED

Region
Auckland
Appointment type
Liquidator
Colin Owens
Deloitte

Sponsored Content

Please login to view

Login or sign up for a free trial.